u/JK_stock

COH is a long standing performer in the health sector. The stock has taken such a massive fall over last few months that it is now at a very cheap P/E of 17. It has been de-rated on short-term earnings softness. Medicare in America has cut assistance to patients needing the hearing implants. But we think the long-term story, however, remains intact. Expansion in markets such as China and India is likely to drive system volumes and upgrade revenue. For Cochlear, AI may improve diagnostics and patient fitting processes, but it doesn’t threaten the core technology.